Target intelligence / Profile preview

Nasopharyngeal bacterial load

Molecular classification
Other (clinical/pathogen load measurement, not a molecule/protein/receptor)
01

Overview

Nasopharyngeal bacterial load is a quantitative measurement of the concentration of bacteria in the nasopharynx, typically assessed by molecular diagnostic methods (e.g., PCR) or culture of nasopharyngeal swabs. It reflects the presence and degree of colonization by potentially pathogenic organisms, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Klebsiella pneumoniae, among others. High levels are associated with an increased risk of respiratory infections, including pneumonia, and may serve as a biomarker for infection risk or severity. Measurement and modulation of nasopharyngeal bacterial load are clinical strategies rather than molecular interventions, and antibiotics are used to reduce pathogenic bacterial burden. This is not a singular molecular entity or canonical therapeutic target, but rather a clinical variable integrating the total bacterial presence in a defined anatomical site.

Other names
Nasopharyngeal bacterial densityNP bacterial loadNasopharyngeal carriage density
02

Mechanism of action

Reduction of nasopharyngeal bacterial load is achieved by antibiotics that inhibit bacterial growth or kill bacteria

03

Biological functions

Marker for risk of pneumonia or systemic infectionIndicator of nasopharyngeal colonization
04

Disease associations

Infection (especially respiratory infections, pneumonia, bacteraemia, and meningitis)
05

Safety considerations

Diagnostic misinterpretation: high bacterial load may not always correlate with symptomatic diseaseAntibiotic resistance in common nasopharyngeal bacteria, e.g., MRSADisruption of normal nasopharyngeal flora due to antibiotics
06

Interacting drugs

Antibiotics targeting common nasopharyngeal bacteria (e.g., Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus)

3 more in the full profile.

07

Biomarkers

High nasopharyngeal bacterial load of S. pneumoniae, H. influenzae, or K. pneumoniae is a biomarker for increased risk of lower respiratory infections or pneumonia

Beyond the preview

Go deeper on Nasopharyngeal bacterial load.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nasopharyngeal bacterial load.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call